Skip to Main Content

Meet Some of Our Faculty

  • Associate Dean of Research and Susan Dwight Bliss Professor of Epidemiology (Chronic Diseases); Deputy Director (Public Health), Yale Center for Clinical Investigation; Deputy Director, Yale Cancer Center

    Melinda L. Irwin, PhD, MPH is the Susan Dwight Bliss Professor of Epidemiology and Associate Dean of Research at the Yale School of Public Health, Deputy Director of the Yale Cancer Center, and Deputy Director (Public Health) in the Yale Center for Clinical Investigation. Nationally, Dr. Irwin co-leads the SWOG Cancer Research Network Cancer Survivorship Committee. In 2018, Dr. Irwin completed the yearlong Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program. Dr. Irwin’s experience working across departments, schools, and with interdisciplinary groups of investigators has provided her with the skills to train and mentor effectively.  Dr. Irwin is a prominent leader in the field of cancer prevention and survivorship research. Her research over the past 20 years has focused on randomized trials of exercise and weight loss on biological markers, treatment side effects and quality of life in people with diagnosed with cancer. She has received funding from the National Institutes of Health, American Cancer Society, Breast Cancer Research Foundation, American Institute for Cancer Research, Komen for the Cure, and Livestrong Foundation. She is currently leading an NCI-funded clinical trial examining the impact of nutrition and exercise on improving chemotherapy completion rate, endocrine therapy adherence, biomarkers, body composition and quality of life in women beginning chemotherapy for breast cancer, and a also leading a newly funded NCI U01 trial of exercise and nutrition on treatment outcomes in women newly diagnosed with ovarian cancer.  Dr. Irwin is committed to training the next generation of scientists and is currently leading an NCI T32-funded Cancer Prevention and Control Training Program for pre- and post-doctoral fellows and an NCI R25-funded Transdisciplinary Research on Energetics and Cancer (TREC) Training Program for early career investigators. At Yale, Dr. Irwin has advised, mentored and trained over 100 trainees. Her commitment to training the next generation of scientists is evident in the enthusiasm she brings to mentoring. Her vision is to maximize opportunities for early career investigators so they can become leaders in their respective fields and have a maximal impact on the health and well-being of patients and the population.
  • Associate Professor of Epidemiology (Microbial Diseases) and of Infectious Diseases; Co-Chair Downs Fellowship, Epidemiology of Microbial Diseases

    Professor Parikh’s research interests focus on translational studies of malaria in sub-Saharan Africa. Dr. Parikh focuses upon several aspects of malaria in sub-Saharan Africa, including studies on optimizing treatment regimens, novel chemoprevention strategies, drug resistance emergence and spread, and parasite dynamics. Current projects include: (1) understanding parasite, drug, and host factors affecting response to artemisinin-based antimalarial therapies using a combination of individual and population-based approaches to inform treatment guidelines (Uganda and Burkina Faso); 2) cluster-randomized trial of endectocides to reduce malaria transmission (Burkina Faso); and 3) characterizing the epidemiology of antimalarial drug resistance and non-falciparum species in sub-Saharan Africa (Cameroon and Burkina Faso), 4) testing of a novel noninvasive diagnostic device for malaria (Cameroon). Dr. Parikh has ongoing projects in several African countries, which utilize observational and cross-sectional designs, as well as prospective clinical trials. Recently, the Parikh lab, in collaboration with colleagues at Colorado State University (Prof Foy), and IRSSINSTech in Burkina Faso (Prof. Dabire and Ouedraogo) were awarded an International Center of Excellence in Malaria Research. Dr. Parikh received his M.D. degree from Johns Hopkins University School of Medicine and completed his medical residency training at the Beth Israel Deaconess Medical Center. After completing his fellowship in Infectious Diseases at the University of California, San Francisco and Masters in Public Health at UC Berkeley he joined the faculty at UCSF. He has been a member of the Department of Epidemiology of Microbial Diseases in the Yale School of Public Health and Section of Infectious Diseases in the Yale School of Medicine since 2012.
  • Assistant Professor of Public Health (Health Policy)

    Jamie Tam is an Assistant Professor in the Department of Health Policy and Management at the Yale School of Public Health. Dr. Tam uses simulation modeling methods to evaluate and understand the impact of tobacco regulations on tobacco use disparities, with a focus on populations with behavioral health conditions. She examines the implications of the relationship between smoking and depression for long-term health outcomes, and how policy interventions could be leveraged to maximize public health benefit. Dr. Tam has developed models that simulate the effects of policies on smoking and population health in the United States, and launched a web-based interface that allows users to explore the potential health effects of different tobacco control policies. She is a co-investigator with the Cancer Intervention and Surveillance Modeling Network (CISNET) consortium and currently co-leads studies evaluating the potential impact of flavor restrictions on tobacco-related health disparities with the Center for the Assessment of Tobacco Regulations (CAsToR)--both NCI-funded cooperative agreements. Dr. Tam was previously a NAM Tobacco Regulatory Science Fellow at the FDA Center for Tobacco Products and was recently recognized as the 2023 recipient of the Society for Research on Nicotine and Tobacco Jarvik-Russell Early Career Award.

Upcoming Events

Jul 20249Tuesday
Jul 202423Tuesday
Sep 202410Tuesday
Sep 202412Thursday
Sep 202418Wednesday
Sep 202420Friday